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Abstract
There is a dearth of data on end-stage renal disease (ESRD) in Africa. Several national renal registries have been established but
have not been sustainable because of resource limitations. The African Association of Nephrology (AFRAN) and the African
Paediatric Nephrology Association (AFPNA) recognize the importance of good registry data and plan to establish an African
Renal Registry. This article reviews the elements needed for a successful renal registry and gives an overview of renal registries
in developed and developing countries, with the emphasis on Africa. It then discusses the proposed African Renal Registry and
the ﬁrst steps towards its implementation. A registry requires a clear purpose, and agreement on inclusion and exclusion
criteria, the dataset and the data dictionary. Ethical issues, data ownership and access, the dissemination of ﬁndings and
funding must all be considered. Well-documented processes should guide data collection and ensure data quality. The ERA-
EDTARegistry is theworld’s oldest renal registry. In Africa, registry data have beenpublishedmainly byNorthAfrican countries,
starting with Egypt and Tunisia in 1975. However, in recent years no African country has regularly reported national registry
data. A shared renal registry would provide participating countries with a reliable technology platform and a common data
dictionary to facilitate joint analyses and comparisons. In March 2015, AFRAN organized a registry workshop for African
nephrologists and then took the decision to establish, for the ﬁrst time, an African Renal Registry. In conclusion, African
nephrologists have decided to establish a continental renal registry. This initiative could make a substantial impact on the
practice of nephrology and the provision of services for adults and children with ESRD in many African countries.
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Background
The continent of Africa has a population of 1.1 billion living in
54 countries. Many African countries are facing the dual burdens
of infectious and non-communicable diseases (NCDs). TheWorld
Health Organization (WHO) estimated that 63% of global deaths
in 2008 were due to NCDs [1], with most occurring in low- and
middle-income countries. There are few studies on NCDs in Af-
rica and there have been calls for more research to be conducted
in this area [2].
While there is widespread concern about the epidemics of
diabetes and cardiovascular disease (CVD), it is less well appre-
ciated that this is accompanied by an epidemic of chronic kidney
disease (CKD) and end-stage renal disease (ESRD). The disease
burden of CKD in Africa is likely to be at least as high as is
reported elsewhere [3, 4]. An increase in ‘lifestyle’ diseases com-
binedwith a high burden of infectious diseasesmay contribute to
a high incidence of CKD and ESRD. Congenital renal problems are
an important cause of CKD in children, with delays in diagnosis
resulting from limited availability of foetal ultrasound screening.
The World Health Assembly recently endorsed the WHO Glo-
bal Action Plan for the Prevention and Control of NCDs 2013–2020
[5]. The targets for this important initiative include a 25% reduc-
tion in prematuremortality fromNCDs by 2025.While CKD is not
explicitlymentioned, the actions that planned have the potential
to make a signiﬁcant impact on the burden of CKD.
There are few published data on CKD in most African coun-
tries [6–8]. A recent systematic review reported a population
prevalence of CKD in sub-Saharan Africa of 13.9% [7] but high-
lighted the need for more studies of good quality. Regarding the
burden of more advanced stages of CKD, the annual incidence of
ESRD in North African countries has been estimated to be around
150 pmp [9, 10]. Anand et al. [11] modelled the incidence of ESRD
in developing regions and predicted an annual incidence of
239 pmp in people with diabetes and hypertension who live in
sub-Saharan Africa. They found that renal replacement therapy
(RRT) use correlated with regional income, with most patients
unable to access RRT. Liyanage et al. [12] estimated that at least
432 000 people in Africa require RRT but are not receiving it.
There seem to be no major differences in the incidence of ESRD
among developing countries [13]. The extremely wide variations
in reported prevalence are therefore mainly a reﬂection of differ-
ing access to dialysis and transplantation [13]. This is strongly as-
sociated with gross national income per capita [3]. It must be
emphasized that, in developing countries, the number of pa-
tients in an RRT programme is an indicator of the provision and
accessibility of RRT services and is not a proxy for the burden of
disease.
The lack of renal registries means that there are few reliable
statistics on RRT fromAfrica. Indeed,most governments in Africa
are probably unaware thatmany of their citizens are dying of kid-
ney disease. Estimates are based mainly on old registry reports
and unpublished data [6, 14], but suggest that the provision of
RRT services has been a low priority for most African countries,
with few state-funded dialysis or transplantation programmes
[6]. In most countries where services are available, patients
carry the full cost and few are able to afford dialysis beyond the
ﬁrst 3 months [15].
Most developed countries have renal registries that provide
critical information to support the planning, delivery and
evaluation of dialysis and transplantation services. In Africa,
where access to treatment is restricted on economic grounds,
the publication of registry data can draw attention to the under-
appreciated problem of CKD and highlight discrepancies in the
provision of RRT services within and between countries. This
may encourage governments and other funders to increase
their support, as has been the case with Tunisia [16]. Further-
more, registry data can aid efforts to prevent, detect and treat
the earlier stages of CKD by identifying the most important
causes of renal disease in each country.
In several African countries, nephrologists have established
renal registries and published data on RRTs. Unfortunately,
most have not been sustainable and in recent years no African
country has regularly published countrywide data on the provi-
sion of RRT. The African Association of Nephrology (AFRAN)
and the African Paediatric Nephrology Association (AFPNA)
have recognized this serious knowledge gap and, at their 2013
congress in Accra, decided to pursue the establishment of a
renal registry for Africa.
Establishing renal registries
Apatient registry collects a deﬁned set of health and demograph-
ic data from patients with a particular disease or who have had a
particular intervention. Such data are held in a central database
andmay include information on longitudinal follow-up and out-
comes [17–19]. Solomon et al. [19] have identiﬁed several factors
required for the successful development of a new registry and
these are included in the sections that follow.
Clarifying the purpose and scope
Early discussions are needed to decide on the purpose, scope and
minimum outputs. Our proposed registry would include adults
and children, in keeping with the adult–paediatric collaboration
thatwas formalized at the 2013 AFRAN/AFPNAmeeting. The pur-
pose would be to generate information on the prevalence, inci-
dence and causes of ESRD in patients on RRT and information
on treatments and outcomes. The aim should be to collect a
small set of well-deﬁned epidemiological data over many years;
any suggestions to turn the registry into a hybrid which also ca-
ters for various research projects or doubles as a practice man-
agement tool should be strenuously resisted. Unnecessary
complexity and ‘scope creep’ will delay implementation dates,
drive up costs and dramatically decrease compliance with data
submission.
Good documentation
Providing information to patients, the public, registry personnel,
colleagues and other registry users is essential and can be done
via the registry website and by providing speciﬁc documents to
the relevant parties as appropriate. There should be clear docu-
mentation on the management structure and key personnel of
the registry, a description of inclusion or exclusion criteria, a
data dictionary, documentation guiding the collection and fur-
ther processing of data, a data access policy, documentation on
conﬁdentiality and ethics issues and copies of all registry
publications.
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Deﬁning and ﬁnding patients to be included
All patientswho receiveRRT for ESRDshouldbe included.Counting
onlypatientswhohave beenondialysis for 90 days leadsto the loss
of important data on patients who start dialysis but cannot con-
tinue for ﬁnancial reasons and those ‘crash landers’ who die
soon after commencing RRT. Documenting all patients with ESRD
who do not access RRT would be extremely useful in highlighting
the treatment gap. This is possible for those patients who are
seenat centres offeringRRTbut it is currently not feasible forall pa-
tients, as most are treated conservatively at local health facilities.
The extent to which all patients are captured impacts on the
precision and level of bias in registry data [20]. Active case ﬁnding
and the use of multiple sources of information increases com-
pleteness but may substantially increase costs. Sources of infor-
mation may include the patients’ doctors, treatment centres,
funders, and suppliers of medications or consumables. Ideally,
reporting should be mandated by law and linked to reimburse-
ment and the licensing of treatment centres.
Determining what data should be recorded
The golden rule is to keep it as simple as possible [21]. This lowers
the costs and time requirements and improves compliance.
Clearly deﬁning the purpose of the registry helps in keeping the
amount of data collected to a minimum. There should be core
items thatwill be collected for the lifetime of the registry and pro-
vision for additional items of time-limited interest. Many regis-
tries focus their annual data collection on 31 December, often
employing a centre questionnaire and a questionnaire for collect-
ing data on individual patients.
The year-end centre questionnaire can produce useful infor-
mation relatively quickly. This allows the registry to report the
numbers of new patients starting RRT in a particular year (inci-
dence), the deaths during that year, the number of patients on
RRTat year-end (prevalence) and the numbers on each treatment
modality.
The individual questionnaire collects demographic and treat-
ment-related information to identify characteristics that may be
related to the development of kidney disease, access to RRT, sur-
vival and other outcomes. Core data collected on each patient
would include the following:
• Country, region and centre
• Patient unique identiﬁcation number and name
• Date of birth and gender
• Ethnicity
• Primary renal disease
• Date and modality of ﬁrst treatment
• Current treatment modality
• Changes of doctor, centre or modality, with dates
• Cessation of treatment or loss to follow-up, with date
• Death date and cause
The capture of additional data would be optional and might in-
clude more detail about the RRT, medications and indicators of
treatment quality. In children, for example, recording height
and weight would be particularly useful.
The data dictionary
The data dictionary describes the elements to be collected by the
registry. This includes specifying the name of the element, data
type (categorical, ordinal, numerical), precision (number of deci-
mal points), range of acceptable values, etc. These deﬁnitions
should conform to those used by well-established registries to
facilitate comparisons and to allow the aggregation of data. The
coding of the primary renal disease is of particular importance
and we would recommend adopting an established system
such as the ERA-EDTA Registry coding scheme [22].
Collecting and cleaning data
This consumes most of the resources required to maintain a
registry. Written standard operating procedures should guide
data collection, entry into the database, and veriﬁcation. Ab-
stracting data from patient records is time consuming and
prone to errors and can be facilitated by using purpose-designed
paper or Web-based forms. Where possible, data should be col-
lected directly from health information systems, as this greatly
improves the accuracy and completeness of data capture and
lowers costs. The UK Renal Registry, for example, extracts data
electronically fromNational Health Service information technol-
ogy systems.
Ensuring data quality
The value of a registry critically depends on data quality. Quality
control processes must focus on data completeness, the preven-
tion of duplicates, validity and accuracy, timeliness, usefulness
of items and the accuracy of data interpretation and reporting
[23]. A high degree of completeness is required for essential
items so that key results such as the incidence and prevalence
are close to their true values.
Random and systematic errors must be minimized. Logical
rules enforced by the database software can ensure that only
plausible values are entered, and internal consistency checks
such as examining the sequences of dates can further reduce
error rates. For example, the system should not allow the entry
of a date for starting RRT that precedes the date of birth or a pri-
mary renal disease of ‘nephropathy due to pre-eclampsia/
eclampsia’ if the gender has been indicated as male. An example
of a systematic error is that black patients aremore likely to be as-
signed a diagnosis of ‘hypertensive kidney disease’ than other
patients with similar clinical histories [24].
Quality control should be built into the system with a feed-
back loop to inform data capturers of errors. It is important to
appreciate that costs will increase as the desired level of com-
pleteness and accuracy required increases or if the data need to
be made available more quickly [19].
Data ownership and data access
Data ownershipwould reside primarilywith the renal societies of
participating countries, who would have full access to their own
data and be able to report their country-speciﬁc ﬁndings. Joint
analyses and reporting of combined data would be the responsi-
bility of the AFRAN Registry Committee. Making information
widely available is a principle common tomany registries and re-
quires a data access policy for responding to requests for data
while safeguarding patient conﬁdentiality.
Dissemination of registry ﬁndings
Routine outputs might include annual reports, presentations at
academic meetings, media releases, publications in medical
journals and the release of datasets. Guidelines on the author-
ship of publications involving combined data should be available.
In principle, each national registry contributing individual pa-
tient data would nominate one author, provided that the criteria
for authorship are met.
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Ethical considerations
There must be scrupulous attention to ethical aspects and rele-
vant privacy and data protection legislation. Patients are mana-
ged in many different treatment centres across each country
and obtaining individual consent would be a daunting task. An
editorial in the NEJM [25] makes the point that public health is
threatened more by incomplete data than individual privacy is
threatened by disease registries. Registries that require written
informed consent achieve only partial enrolment and limit our
ability to evaluate and optimize care for patients.
The collection of data involves minimal risk to patients, as
identiﬁable information would be protected from improper use
and disclosure. For the South African Renal Registry, a waiver
was granted by the Health Research Ethics Committee of Stellen-
bosch University so that individual consent does not have to be
obtained. This is similar to the practice of the UK Renal Registry,
the Scottish Renal Registry, and the French Renal Epidemiology
and Information Network. Each country participating in the Afri-
can registry initiative will need approval from its local ethics
committee andwewould recommend applying for awaiver of in-
dividual consent.
Funding
Establishing and operating a renal registry is resource intensive,
and securing sustainable funding is critical to its success.
AFRAN/AFPNA and the national societies will have to liaise
with governments, industry and other funders and this is likely
to be challenging in an environment where treatment provision
is generally seen as unaffordable. Data collection often consumes
most of the budget and few resources are then available for qual-
ity control, data analysis and reporting of ﬁndings. Considerable
resources will be spent on establishing a registry and we should
ensure that it does not fail thereafter because of a lack of funding.
Renal registries in developed and developing
countries
The European Renal Association-European Dialysis and
Transplant Association (ERA-EDTA) Registry and other
registries
The ERA-EDTA Registry is the world’s oldest renal registry,
started in 1964 [26, 27].WillemDrukker reported on patients trea-
tedwith chronic dialysiswhile Frank Parsons ﬁrst reported onpa-
tients who had been transplanted [28]. The registry currently
publishes an annual report and a number of scientiﬁc papers
each year. It also plays an active educational role, offering
courses in epidemiology and hosting visiting researchers while
providing them with training in data analysis.
Many other registries have followed, including the Australia
and New Zealand Dialysis and Transplant Registry (ANZDATA,
1977), the Canadian Organ Replacement Register (CORR, 1981),
the Japanese registry (1983) [29], theUnited States Renal Data Sys-
tem (USRDS, 1988), the Scottish Renal Registry (1991), the Malay-
sian Renal Registry (1992) and the UK Renal Registry (1995).
The 2014 USRDS report [30] presents data from 54 countries in
its chapter on international comparisons. The countries include
Indonesia, Thailand, Colombia, Mexico, Uruguay, Argentina and
Brazil. Data fromAfrican countries have been notably absent, but
the inclusion of the South African data in the 2014 USRDS report
may herald the start of a new era where reliable data on RRT in
Africa are published regularly.
Renal registries from countries in Africa
Few renal registries have been established in African countries.
Most havebeen fromNorthAfrica, but reports have not been pub-
lished regularly. The earliest reports are from Egypt and Tunisia
in 1975, followed by South Africa in 1977 and thereafter by Libya,
Algeria and Morocco.
Nephrologists from North African countries have contributed
data to the ERA-EDTA Registry (Table 1), starting with Egypt and
Tunisia, whose data from 1975 to 1977 were included in the 1978
report. Libya joined in 1980, followed by Algeria in 1981 and Mo-
rocco in 1995. The last contribution from a North African country
was in 2008.
The Egyptian Renal Registry’s ﬁrst report described its 1996
data [31] while the last reported data is from 2008 [32]. The Tunis-
ian dialysis registry was established in 1990 and had a major im-
pact on the country’s development of RRT [16]. Registry data
inﬂuenced decisions to increase the numberof nephrologists, de-
velop a new transplant programme, start new dialysis units and
develop a kidney disease prevention programme. However, the
registry stopped functioning after 2011. The Moroccan Registry
for End-Stage Renal Disease (Magredial) was started in 2006 by
theMinistry of Health in collaborationwith theMoroccan Society
of Nephrology and the Agence de Biomédecine. Its ﬁrst report
was published in 2008 [33]. Unfortunately, this registry subse-
quently experienced enormous difﬁculties related to a lack of re-
sources and poor compliance with data submission and has not
produced further reports.
The Nigerian Renal Registry was conceived 20 years ago, with
sporadic reports presented at annual congresses. Complex ques-
tionnaires signiﬁcantly limited participation. A simpliﬁed ver-
sion was introduced in 2014 and data from a few participating
centreswere presented at the 2015 Nigerian Association of Neph-
rology meeting (F. Arogundade, personal communication).
The South African Dialysis and Transplant Registry was
started by Koppel Furman in 1977. The last annual report de-
scribed the 1994 data and the registry then stopped functioning
due to a lack of resources. It has now been re-established as the
South African Renal Registry and the ﬁrst report provides an ana-
lysis of the 2012 data on RRT across the country [34].
An African Renal Registry
There are good reasons for establishing an African Renal Registry
as a single entity. They include the following:
• Resources would be combined and costs shared by participat-
ing national renal societies.
• Improvements to the technology platform would be available
to all countries simultaneously.
• Fundraising is likely to be easier with the participation of
many different countries.
Table 1. Contributions of data to the ERA-EDTA Registry by North
African countries. The dates refer to the dates of data collection and
not the publication dates of the registry reports
Country
First/last data
submissions Comments
Algeria 1981/1997 No data submitted for 1994
Egypt 1975/1996 No data for 1978–80, 1994–5
Libya 1980/1996 No data for 1993–4
Morocco 1995/1997
Tunisia 1975/2008 No data for 1978–80, 1994, 1998–2000, 2006
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• Sharing of expertise related to the technology platform, epi-
demiology, statistical analysis and scientiﬁc writing.
• A single data dictionary and the collection of a common set of
data to facilitate joint analyses and the comparison of ﬁnd-
ings between countries.
• More effective patient advocacy.
The role of AFRAN/AFPNA and the national renal
associations
The African Renal Registry is a project of AFRAN/AFPNA and its
member societies, who will assist in securing funding from gov-
ernments, industry and international funding agencies. This is
essential to support the central registry platform and to support
operations within participating countries. We will also draw on
expertise available from outside Africa. Experienced colleagues
from the ERA-EDTA Registry, UK Renal Registry and USRDS, for
example, have indicated their willingness to assist.
First steps toward implementation
The AFRAN General Meeting in March 2015 decided that an
African Renal Registry should be developed that allows national
societies tomaintain control over their owndata and the freedom
to report their own ﬁndings but also allows the aggregation of all
data for joint analyses and comparisons. It will utilize the Inter-
net-based platform of the South African Renal Registry. The in-
tention is to pilot the registry in selected African countries and
then extend this to all interested countries.
Workshop report: SARS-AFRAN-ERA-EDTA Renal
Registry Workshop, 12 March 2015
Another practical step forward has been taken in the form of a
workshop for nephrologists from African countries who are in-
volved with their own renal registries or who have been man-
dated by their national societies to lead the development of a
new registry. On behalf of AFRAN, Razeen Davids of the South
African Renal Registry organized the workshop just before the
World Congress of Nephrology (WCN) in Cape Town. The aim
was to provide training on starting a renal registry and improving
the quality of existing registries and to introduce basic principles
of epidemiology and data analysis.
The programme included topics such as data quality, data-
bases and software, coding and deﬁnitions, data security and
statistical analysis. The presentations were delivered by Kitty
Jager and her team from the ERA-EDTA Registry, with contribu-
tions from Fergus Caskey (UK Renal Registry), Cecile Couchoud
(the French registry, REIN) and Razeen Davids. The workshop
was attended by 28 delegates from 11 African countries as well
as delegates from New Zealand, the UK and Brazil. The list of de-
legates and speakers is provided as an appendix.
This workshop, and the decisions that were made at the
AFRAN General Meeting at theWCN inMarch 2015, marks the of-
ﬁcial launching of the African Renal Registry.
Conclusions
African nephrologists have a unique opportunity to establish a
continental renal registry. We believe that this is an initiative
whose time has come and that it has the potential to make a sub-
stantial impact on the practice of nephrology and the provision of
services for patients with CKD and ESRD on the African continent.
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Appendix 1
Table A1. List of workshop delegates and speakers
Delegates from African countries
Cameroon François Folefack Kaze
Ghana Dwomoa Adu, Vincent Boima, Charlotte Osafo, Elliot Tannor
Kenya Mathew Koech, George Moturi
Nigeria Gbenga Awobusuyi, Felicia Eke, Chris Esezobar, Zumnan Gimba, Ulasi Ifeoma, Ogiator Monday, Daniel Uchendu
Senegal Sidy Seck
South Africa Julian Jacobs, Stefano Mestriner, Adriano Pellizon, Sarala Naicker
Sudan Mohamed Elamin Awad
Tanzania Jacquelien Shoo, Kessy Shija, Onesmo Kisanga, Frederick Francis
Tunisia Faiçal Jarraya
Uganda Emmanuel Ssekasanvu
Zambia Kenneth Kapembwa, Aggrey Mweemba
Delegates from other countries
Brazil Jose Divino
New Zealand Gillian Balbir Singh
United Kingdom John Eastwood, Malcolm Lewis
Speakers
The Netherlands Kitty Jager, Anneke Kramer, Marlies Noordzij
United Kingdom Fergus Caskey
France Cecile Couchoud
South Africa Razeen Davids, Jimmy Volmink (Faculty Dean, Stellenbosch University)
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